Green & Blue Wines
Food & Beverage · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 26 Bedford Rd, London, Greater London...Phone Number
+44 2086939250Website
www.greenandbluewines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Green & Blue Wines
Mirdametinib is a company focused on developing transformative cancer therapies, particularly through its MEK inhibitor product. The company also offers Carfilzomib (PR-171), a second-generation proteasome inhibitor approved for treating relapsed or refractory multiple myeloma. Their products are intended for patients who have failed previous lines of therapy, aiming to improve survival rates and manage treatment-related cardiotoxicity. Mirdametinib's research emphasizes understanding the safety profiles and efficacy of their therapies in clinical settings.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Green & Blue Wines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Green & Blue Wines is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Green & Blue Wines
Click to see if Green & Blue Wines had a recent Job posting/layoffs
Earning: See what the market has to say on Green & Blue Wines recently announced quarterly report
Green & Blue Wines, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Green & Blue Wines launches new products
Check if Green & Blue Wines has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Green & Blue Wines has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Green & Blue Wines
Compare insights from companies similar to Green & Blue Wines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Green & Blue Wines
<$5M
11-50
Private
-
2005
N/A
Company Profile Activity
Activity Insights
Green & Blue Wines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Green & Blue Wines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Green & Blue Wines.
Green & Blue Wines Tech Stack
A closer look at the technologies used by Green & Blue Wines
Top Food & Beverage Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Green & Blue Wines
Sign Up For FreeTo access detailed company insights
Mirdametinib is a company focused on developing transformative cancer therapies, particularly through its MEK inhibitor product. The company also offers Carfilzomib (PR-171), a second-generation proteasome inhibitor approved for treating relapsed or refractory multiple myeloma. Their products are intended for patients who have failed previous lines... Read More
